Addex Therapeutics Ltd. (ADXN)
3.75
-0.30
(-7.41%)
USD |
NASDAQ |
Aug 25, 16:00
3.76
+0.01
(+0.27%)
After-Hours: 19:59
Addex Therapeutics Total Liabilities (Quarterly) : 1.832M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.832M |
| December 31, 2025 | 2.016M |
| September 30, 2025 | 1.725M |
| June 30, 2025 | 1.625M |
| March 31, 2025 | 1.344M |
| December 31, 2024 | 1.105M |
| September 30, 2024 | 1.311M |
| June 30, 2024 | 1.164M |
| March 31, 2024 | 5.228M |
| December 31, 2023 | 4.154M |
| September 30, 2023 | 2.398M |
| June 30, 2023 | 3.211M |
| March 31, 2023 | 3.528M |
| December 31, 2022 | 3.642M |
| September 30, 2022 | 4.358M |
| June 30, 2022 | 4.721M |
| March 31, 2022 | 5.136M |
| December 31, 2021 | 6.158M |
| September 30, 2021 | 5.059M |
| June 30, 2021 | 5.527M |
| March 31, 2021 | 6.562M |
| December 31, 2020 | 6.304M |
| September 30, 2020 | 4.248M |
| June 30, 2020 | 4.586M |
| March 31, 2020 | 7.332M |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 80.09B |
| Roche Holding AG | -- |
| Oculis Holding AG | 38.43M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.920M |
| Shareholders Equity (Quarterly) | 4.087M |
| Debt to Equity Ratio | 0.0311 |
| Current Ratio | 0.9715 |
| Net Debt Paydown Yield | -0.26% |